Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

New Genetic Test Detects Heart Disease, Diabetes, Cancer Skip to content

There's always more to discover with an AARP membership! Check out your member benefits.

 

Researchers Predict New Genetic Test for Heart Disease 

Method could also flag other diseases, like diabetes and breast cancer

A doctor examines DNA chart

Getty Images

En español |  Imagine a day when you might take a cheek swab, mail it off as you would to a company similar to one like 23andME.com, and receive back your odds of developing a common type of heart disease — as well as type 2 diabetes, inflammatory bowel disease, breast cancer or an irregular heartbeat.

That day could arrive in about five years, estimate researchers from the Broad Institute, Massachusetts General Hospital and Harvard Medical School, who published a paper on their new genetic scoring system in the journal Nature Genetics this week.


AARP Health Tool: Heart Disease


Their method, they explain, breaks from the hunt for a single gene mutation that ups your risk of a specific disease — say, the BRCA gene that contributes to a small number of breast cancer cases. Instead, they search for tiny mutations within the genetic code — but millions and millions of them — which, analyzed on the whole, give insight into the chances of developing certain diseases.

The potential for heart disease prevention in particular is huge, cardiologists said in reacting to the news. Using the new method, for instance, researchers estimate that up to 25 million Americans who don't have warning signs like high cholesterol could be walking around with three times the average person's risk of heart disease. 

"What I foresee is in five years, each person will know this risk number, this 'polygenic risk score,' similar to the way each person knows his or her cholesterol," Sekar Kathiresan, M.D., director of the Center for Genomic Medicine at Massachusetts General Hospital, who led the research team, told the New York Times

In releasing their paper, the Boston-based team stressed that an increased likelihood of a particular disease their method could uncover does not equal a diagnosis. Nor does it give anyone a “free pass” to ignore advice on diet and exercise that could also help lower disease risk. But the information could, in theory, lead a doctor to prescribe a statin for someone who’s 40 with no other known risk factors for heart disease, potentially helping the patient to avoid a deadly heart attack.

Join the Discussion

0 | Add Yours

Please leave your comment below.

You must be logged in to leave a comment.

GO TO THIS ARTICLE